PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

May 20, 2026

Study Completion Date

October 20, 2026

Conditions

Heart ArrestSeizuresStatus Epilepticus

Interventions

DRUG

Perampanel

Perampanel is a non-competitive AMPA glutamate receptor antagonist.

DRUG

Placebo

Trial Locations (1)

RECRUITING

Zuckerberg San Francisco General Hospital, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER